{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T18:10:28Z","timestamp":1788113428791,"version":"build-2803163510"},"reference-count":168,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S18523N"],"award-info":[{"award-number":["1S18523N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>New diagnostic methods and treatments have significantly decreased the mortality rates of cancer patients, but further improvements are warranted based on the identification of novel tumor-promoting molecules that can serve as therapeutic targets. The macrophage migration inhibitory factor (MIF) family of cytokines, comprising MIF and DDT (also known as MIF2), are overexpressed in almost all cancer types, and their high expressions are related to a worse prognosis for the patients. MIF is involved in 9 of the 10 hallmarks of cancer, and its inhibition by antibodies, nanobodies, or small synthetic molecules has shown promising results. Even though DDT is also proposed to be involved in several of the hallmarks of cancer, the available information about its pro-tumoral role and mechanism of action is more limited. Here, we provide an overview of the involvement of both MIF and DDT in cancer, and we propose that blocking both cytokines is needed to obtain the maximum anti-tumor response.<\/jats:p>","DOI":"10.3390\/cancers15020395","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T04:47:08Z","timestamp":1673239628000},"page":"395","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Hallmarks of Cancer Affected by the MIF Cytokine Family"],"prefix":"10.3390","volume":"15","author":[{"given":"Romina","family":"Mora Barthelmess","sequence":"first","affiliation":[{"name":"Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, 1050 Brussels, Belgium"},{"name":"Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0082-9751","authenticated-orcid":false,"given":"Benoit","family":"Stijlemans","sequence":"additional","affiliation":[{"name":"Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, 1050 Brussels, Belgium"},{"name":"Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4442-7474","authenticated-orcid":false,"given":"Jo A.","family":"Van Ginderachter","sequence":"additional","affiliation":[{"name":"Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, 1050 Brussels, Belgium"},{"name":"Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, 1050 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fphar.2018.01300","article-title":"Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium","volume":"9","author":"Falzone","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fonc.2018.00086","article-title":"Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations","volume":"8","author":"Seidel","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fphar.2019.00387","article-title":"Safety and Efficacy of Anti-PD-1 Monoclonal Antibodies in Patients With Relapsed or Refractory Lymphoma: A Meta-Analysis of Prospective Clinic Trails","volume":"10","author":"Zhou","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_4","unstructured":"National Institutes of Health (NIH) (2022, November 07). Pembrolizumab, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/pembrolizumab."},{"key":"ref_5","unstructured":"National Institutes of Health (NIH) (2022, November 07). Nivolumab, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/nivolumab."},{"key":"ref_6","unstructured":"National Institutes of Health (NIH) (2022, November 07). Ipilimumab, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/ipilimumab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/01.MP.0000071841.17900.69","article-title":"Overexpression of VEGF and angiopoietin 2: A key to high vascularity of hepatocellular carcinoma?","volume":"16","author":"Moon","year":"2003","journal-title":"Mod. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1073\/pnas.1525360113","article-title":"Ang-2\/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival","volume":"113","author":"Kloepper","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1073\/pnas.56.1.72","article-title":"Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction","volume":"56","author":"David","year":"1966","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1021\/bi982184o","article-title":"Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution","volume":"38","author":"Sugimoto","year":"1999","journal-title":"Biochemistry"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lee, S.H., Kwon, H.J., Park, S., Kim, C.I., Ryu, H., Kim, S.S., Park, J.B., and Kwon, J.T. (2021). Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0257375"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/IGC.0000000000000951","article-title":"Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer","volume":"27","author":"Wang","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2007.11.028","article-title":"Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer","volume":"261","author":"Xu","year":"2008","journal-title":"Cancer Lett."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Michelet, C., Danchin, E.G.J., Jaouannet, M., Bernhagen, J., Panstruga, R., Kogel, K.H., Keller, H., and Coustau, C. (2019). Cross-Kingdom Analysis of Diversity, Evolutionary History, and Site Selection within the Eukaryotic Macrophage Migration Inhibitory Factor Superfamily. Genes, 10.","DOI":"10.3390\/genes10100740"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.drudis.2018.11.003","article-title":"Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: From pathogenic factors to therapeutic targets","volume":"24","author":"Gunther","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e652","DOI":"10.1002\/ctm2.652","article-title":"Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-kappaB\/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis","volume":"12","author":"Zheng","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"155121","DOI":"10.1016\/j.cyto.2020.155121","article-title":"Immune modulation by the macrophage migration inhibitory factor (MIF) family: D-dopachrome tautomerase (DDT) is not (always) a backup system","volume":"133","author":"Illescas","year":"2020","journal-title":"Cytokine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cyto.2012.03.014","article-title":"D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family","volume":"59","author":"Merk","year":"2012","journal-title":"Cytokine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/nep.12353","article-title":"Macrophage migration inhibitory factor -173G\/C gene polymorphism increases the risk of renal disease: A meta-analysis","volume":"20","author":"Tong","year":"2015","journal-title":"Nephrology"},{"key":"ref_20","first-page":"601","article-title":"The association between the migration inhibitory factor -173G\/C polymorphism and cancer risk: A meta-analysis","volume":"8","author":"Zhang","year":"2015","journal-title":"Onco Targets Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e23209","DOI":"10.1002\/jcla.23209","article-title":"Association of the genetic variants (-794 CATT5-8 and -173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFalpha in women with breast cancer","volume":"34","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/acs.biochem.7b01156","article-title":"Role of the Cysteine 81 Residue of Macrophage Migration Inhibitory Factor as a Molecular Redox Switch","volume":"57","author":"Schinagl","year":"2018","journal-title":"Biochemistry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.4049\/jimmunol.1500572","article-title":"Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions","volume":"195","author":"Thiele","year":"2015","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.freeradbiomed.2015.09.009","article-title":"Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function","volume":"89","author":"Dickerhof","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.str.2022.03.007","article-title":"Redox-Dependent structure and dynamics of macrophage migration inhibitory factor reveal sites of latent allostery","volume":"30","author":"Skeens","year":"2022","journal-title":"Structure"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"73486","DOI":"10.18632\/oncotarget.11970","article-title":"Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer","volume":"7","author":"Schinagl","year":"2016","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/bcp.14289","article-title":"Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours","volume":"86","author":"Mahalingam","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: A regulator of innate immunity","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00018-021-04038-8","article-title":"Macrophage migration inhibitory factor family proteins are multitasking cytokines in tissue injury","volume":"79","author":"Song","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1038\/s41467-021-23264-z","article-title":"MIF is a 3\u2019 flap nuclease that facilitates DNA replication and promotes tumor growth","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","article-title":"Evolving complexity of MIF signaling","volume":"57","author":"Jankauskas","year":"2019","journal-title":"Cell Signal."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/414920a","article-title":"MIF regulates innate immune responses through modulation of TLR-4","volume":"414","author":"Roger","year":"2001","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.4049\/jimmunol.0803710","article-title":"The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor","volume":"182","author":"Merk","year":"2009","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(03)00900-1","article-title":"Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter","volume":"551","author":"Flieger","year":"2003","journal-title":"FEBS Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04581-2","article-title":"Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation","volume":"9","author":"Lang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.40672","article-title":"Macrophage migration inhibitory factor regulates U1-snRNP immune complex mediated activation of the NLRP3 inflammasome","volume":"71","author":"Shin","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/imcb.12376","article-title":"Necrotic cell death increases the release of macrophage migration inhibitory factor by monocytes\/macrophages","volume":"98","author":"Dankers","year":"2020","journal-title":"Immunol. Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1002\/jcp.29456","article-title":"Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair","volume":"235","author":"Liu","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"791187","DOI":"10.3389\/fcell.2021.791187","article-title":"Exosomal MIF Derived From Nasopharyngeal Carcinoma Promotes Metastasis by Repressing Ferroptosis of Macrophages","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Aiello","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"E577","DOI":"10.1073\/pnas.1102941108","article-title":"The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)","volume":"108","author":"Merk","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.24272\/j.issn.2095-8137.2020.003","article-title":"D-dopachrome tautomerase from Japanese sea bass (Lateolabrax japonicus) is a chemokine-like cytokine and functional homolog of macrophage migration inhibitory factor","volume":"41","author":"Xu","year":"2020","journal-title":"Zool. Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lindner, R. (2017). Invariant Chain Complexes and Clusters as Platforms for MIF Signaling. Cells, 6.","DOI":"10.3390\/cells6010006"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"30067","DOI":"10.1038\/srep30067","article-title":"Relationship between elevated soluble CD74 and severity of experimental and clinical ALI\/ARDS","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41419-022-04552-y","article-title":"Interplay between soluble CD74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma","volume":"13","author":"Fukuda","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20030286","article-title":"MIF signal transduction initiated by binding to CD74","volume":"197","author":"Leng","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S616","DOI":"10.21037\/tcr.2016.10.06","article-title":"The emerging role of chemokine receptor CXCR2 in cancer progression","volume":"5","author":"Jaffer","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1158\/1541-7786.MCR-10-0288","article-title":"Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts","volume":"8","author":"Tarnowski","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1038\/s41467-020-19764-z","article-title":"Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting","volume":"11","author":"Kontos","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"15881","DOI":"10.1074\/jbc.M116.717751","article-title":"Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: Evidence for partial allosteric agonism in comparison with CXCL12 chemokine","volume":"291","author":"Rajasekaran","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1038\/s41598-018-23554-5","article-title":"Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4","volume":"8","author":"Lacy","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"127171","DOI":"10.1172\/JCI127171","article-title":"MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model","volume":"131","author":"Tilstam","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"103412","DOI":"10.1016\/j.ebiom.2021.103412","article-title":"D-dopachrome tautomerase contributes to lung epithelial repair via atypical chemokine receptor 3-dependent Akt signaling","volume":"68","author":"Song","year":"2021","journal-title":"EBioMedicine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/35041591","article-title":"Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1","volume":"408","author":"Kleemann","year":"2000","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.febslet.2005.01.080","article-title":"Binding of JAB1\/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif","volume":"579","author":"Finkelmeier","year":"2005","journal-title":"FEBS Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.4049\/jimmunol.181.4.2330","article-title":"Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase","volume":"181","author":"Coleman","year":"2008","journal-title":"J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-2867-13-28","article-title":"Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis","volume":"13","author":"Guo","year":"2013","journal-title":"Cancer Cell Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.sjbs.2020.04.027","article-title":"The expression of macrophage migration inhibitory factor in the non-small cell lung cancer","volume":"27","author":"Zhang","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1021\/acs.jmedchem.1c01598","article-title":"Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione Derivative Inhibits d-Dopachrome Tautomerase Activity and Suppresses the Proliferation of Non-Small Cell Lung Cancer Cells","volume":"65","author":"Xiao","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-02992-y","article-title":"Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer","volume":"11","author":"Charan","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Balogh, K.N., Templeton, D.J., and Cross, J.V. (2018). Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197702"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Meyer-Siegler, K.L., Iczkowski, K.A., and Vera, P.L. (2005). Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer. BMC Cancer, 5.","DOI":"10.1186\/1471-2407-5-73"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.4049\/jimmunol.177.12.8730","article-title":"Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells","volume":"177","author":"Iczkowski","year":"2006","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/cncr.10354","article-title":"Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma","volume":"94","author":"Bellino","year":"2002","journal-title":"Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/IGC.0b013e31821c45b7","article-title":"Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma","volume":"21","author":"Cheng","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cncr.20818","article-title":"Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma","volume":"103","author":"Hira","year":"2005","journal-title":"Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijc.11287","article-title":"Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma","volume":"20","author":"Ren","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3892\/ol.2021.12810","article-title":"MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma","volume":"22","author":"Qin","year":"2021","journal-title":"Oncol Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1002\/cncr.24609","article-title":"Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer","volume":"115","author":"Xia","year":"2009","journal-title":"Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"9916","DOI":"10.3748\/wjg.v21.i34.9916","article-title":"Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer","volume":"21","author":"He","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/gut.2005.078113","article-title":"Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: Potential role of MIF in gastric carcinogenesis","volume":"55","author":"He","year":"2006","journal-title":"Gut"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/carcin\/bgh279","article-title":"Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs","volume":"26","author":"Xia","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3389\/fimmu.2020.01191","article-title":"Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression","volume":"11","author":"Alban","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1038\/onc.2016.160","article-title":"MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis","volume":"35","author":"Ghoochani","year":"2016","journal-title":"Oncogene"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/stem.2393","article-title":"Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion","volume":"34","author":"Otvos","year":"2016","journal-title":"Stem Cells"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1074\/jbc.M113.500694","article-title":"Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis","volume":"289","author":"Pasupuleti","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/ijc.30278","article-title":"D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth","volume":"139","author":"Guo","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Cavalli, E., Mazzon, E., Mammana, S., Basile, M.S., Lombardo, S.D., Mangano, K., Bramanti, P., Nicoletti, F., Fagone, P., and Petralia, M.C. (2019). Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma. Brain Sci., 9.","DOI":"10.3390\/brainsci9100284"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"103","DOI":"10.18632\/oncotarget.1560","article-title":"The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma model.pdf","volume":"5","author":"Kobold","year":"2013","journal-title":"Oncotarget"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Oliveira, C.S., E De Bock, C., Molloy, T.J., Sadeqzadeh, E., Geng, X.Y., Hersey, P., Zhang, X.D., and Thorne, R.F. (2014). Macrophage migration inhibitory factor engages PI3K\/Akt signalling and is a prognostic factor in metastatic melanoma. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-630"},{"key":"ref_82","first-page":"5233","article-title":"Macrophage Migration-inhibitory Factor Levels in Serum of Patients with Ovarian Cancer Correlates with Poor Prognosis","volume":"32","author":"Krockenberger","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_84","first-page":"31","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Am. Assoc. Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s43042-020-00089-x","article-title":"Exploring the multiple roles of guardian of the genome: P53","volume":"21","author":"Feroz","year":"2020","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/cdd.2017.169","article-title":"How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?","volume":"25","author":"Aubrey","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1073\/pnas.1533295100","article-title":"The p53-dependent effects of MIF revealed by gene targeting","volume":"100","author":"Petrenko","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1158\/0008-5472.CAN-15-1011","article-title":"MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53","volume":"76","author":"Fukaya","year":"2016","journal-title":"Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.placenta.2016.03.001","article-title":"Macrophage migration inhibitory factor induces phosphorylation of Mdm2 mediated by phosphatidylinositol 3-kinase\/Akt kinase: Role of this pathway in decidual cell survival","volume":"41","author":"Costa","year":"2016","journal-title":"Placenta"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"20383","DOI":"10.1074\/jbc.M800050200","article-title":"Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity","volume":"283","author":"Jung","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.onc.1208353","article-title":"Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis","volume":"24","author":"Corcoran","year":"2005","journal-title":"Oncogene"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1158\/1541-7786.MCR-10-0101","article-title":"The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through beta-catenin-dependent and -independent mechanisms","volume":"8","author":"Xin","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0092-8674(00)80714-X","article-title":"Active Transcriptional Repression by the Rb\u2013E2F Complex Mediates G1 Arrest Triggered by p16INK4a, TGFb, and Contact Inhibition.pdf","volume":"97","author":"Zhang","year":"1999","journal-title":"Cell"},{"key":"ref_94","first-page":"579","article-title":"Suppression of tumor growth through introduction of an antisense plasmid of macrophage migration inhibitory factor","volume":"10","author":"Sasaki","year":"2002","journal-title":"Int. J Mol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(00)00008-8","article-title":"Smac, a Mitochondrial Protein that Promotes Cytochrome c\u2013Dependent Caspase Activation by Eliminating IAP Inhibition","volume":"102","author":"Du","year":"2000","journal-title":"Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.addr.2009.05.009","article-title":"Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications","volume":"61","author":"Bolanos","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41419-018-0408-1","article-title":"Cytochrome c speeds up caspase cascade activation by blocking 14-3-3epsilon-dependent Apaf-1 inhibition","volume":"9","author":"Orzaez","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1038\/sj.onc.1210318","article-title":"Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5\/JAB1 in the control of autocrine MIF activity","volume":"26","author":"Lue","year":"2007","journal-title":"Oncogene"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"19740","DOI":"10.1074\/jbc.RA118.003935","article-title":"Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-kappaB signaling","volume":"293","author":"De","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1073\/pnas.012511599","article-title":"Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53- Regulatory role in the innate immune response","volume":"99","author":"Mitchell","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1096\/fj.03-0110com","article-title":"Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway","volume":"17","author":"Baumann","year":"2003","journal-title":"Faseb J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/JLB.3A0420-242RRR","article-title":"Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells","volume":"110","author":"Schindler","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e005475","DOI":"10.1136\/jitc-2022-005475","article-title":"OxMIF: A druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases","volume":"10","author":"Thiele","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"R435","DOI":"10.1016\/j.cub.2014.04.012","article-title":"DNA replication and oncogene-induced replicative stress","volume":"24","author":"Hills","year":"2014","journal-title":"Curr. Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"564601","DOI":"10.3389\/fcell.2020.564601","article-title":"PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance","volume":"8","author":"Rose","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.currproblcancer.2010.12.002","article-title":"PARP inhibitor treatment in ovarian and breast cancer","volume":"35","author":"Weil","year":"2011","journal-title":"Curr. Probl. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S1097-2765(02)00736-0","article-title":"Flap Endonuclease 1 Efficiently Cleaves Base Excision Repair and DNA Replication Intermediates Assembled into Nucleosomes","volume":"10","author":"Huggins","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3892\/or.2013.2946","article-title":"Significance of the vascular endothelial growth factor and the macrophage migration inhibitory factor in the progression of hepatocellular carcinoma","volume":"31","author":"Wang","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1365-2990.2002.00416.x","article-title":"Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression","volume":"28","author":"Manaut","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12957-016-0797-5","article-title":"Macrophage migration inhibitory factor regulating the expression of VEGF-C through MAPK signal pathways in breast cancer MCF-7 cell","volume":"14","author":"Zhang","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1158\/1535-7163.MCT-07-0118","article-title":"Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis","volume":"6","author":"Hagemann","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03402061","article-title":"An Essential Role for Macrophage Migration Inhibitory Factor (MIF) in Angiogenesis and the Growth of a Murine Lymphoma","volume":"5","author":"Chesney","year":"1999","journal-title":"Mol. Med."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Ma, Y., Su, K.N., Pfau, D., Rao, V.S., Wu, X., Hu, X., Leng, L., Du, X., Piecychna, M., and Bedi, K. (2019). Cardiomyocyte d-dopachrome tautomerase protects against heart failure. JCI Insight, 4.","DOI":"10.1172\/jci.insight.128900"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00006676-200301000-00010","article-title":"Hypoxia-Inducible Factor 1 Regulates Vascular Endothelial Growth Factor Expression in Human Pancreatic Cancer","volume":"26","author":"Reber","year":"2003","journal-title":"Pancreas"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/HP.S93413","article-title":"The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy","volume":"3","author":"Muz","year":"2015","journal-title":"Hypoxia (Auckl)"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12035-014-8727-4","article-title":"Hypoxia signaling regulates macrophage migration inhibitory factor (MIF) expression in stroke","volume":"51","author":"Zis","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_117","first-page":"1541","article-title":"Modulation of Hypoxia-inducible Factor 1a Expression by the Epidermal Growth Factor: Phosphatidylinositol 3-Kinase:PTEN:AKT:FRAP Pathway in Human Prostate Cancer Cells- Implications for Tumor Angiogenesis and Therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Oda, S., Oda, T., Nishi, K., Takabuchi, S., Wakamatsu, T., Tanaka, T., Adachi, T., Fukuda, K., Semenza, G.L., and Hirota, K. (2008). Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002215"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1158\/0008-5472.CAN-15-2841","article-title":"A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fcell.2020.00760","article-title":"Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming","volume":"8","author":"Lai","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/jbmr.3112","article-title":"N-cadherin Regulation of Bone Growth and Homeostasis Is Osteolineage Stage-Specific","volume":"32","author":"Fontana","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1111\/jcmm.17352","article-title":"MIF\/SCL3A2 depletion inhibits the proliferation and metastasis of colorectal cancer cells via the AKT\/GSK-3beta pathway and cell iron death","volume":"26","author":"Huang","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mc.22979","article-title":"MIF promotes perineural invasion through EMT in salivary adenoid cystic carcinoma","volume":"58","author":"Zhang","year":"2019","journal-title":"Mol. Carginog."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"80358","DOI":"10.18632\/oncotarget.18673","article-title":"Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4:AKT:EMT pathway in human glioblastoma cells","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2022.8288","article-title":"Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells","volume":"47","author":"Zhang","year":"2022","journal-title":"Oncol. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"110171","DOI":"10.1016\/j.celrep.2021.110171","article-title":"Macrophages are metabolically heterogeneous within the tumor microenvironment","volume":"37","author":"Geeraerts","year":"2021","journal-title":"Cell Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s11033-015-3858-x","article-title":"Cancer metabolism and the Warburg effect: The role of HIF-1 and PI3K","volume":"42","author":"Courtnay","year":"2015","journal-title":"Mol. Biol. Rep."},{"key":"ref_129","first-page":"1062","article-title":"Macrophage migration inhibitory factor promotes Warburg effect via activation of the NFkappaB\/HIF1alpha pathway in lung cancer","volume":"41","author":"Li","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/cam4.686","article-title":"GABAB R\/GSK-3beta\/NF-kappaB signaling pathway regulates the proliferation of colorectal cancer cells","volume":"5","author":"Shu","year":"2016","journal-title":"Cancer Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"18522","DOI":"10.1074\/jbc.RA119.009860","article-title":"A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity","volume":"294","author":"Tilstam","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10555-010-9223-6","article-title":"Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity","volume":"29","author":"DeNardo","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"ref_134","first-page":"1","article-title":"Inflammation and tumor progression: Signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"E8421","DOI":"10.1073\/pnas.1712288114","article-title":"MIF and D-DT are potential disease severity modifiers in male MS subjects","volume":"114","author":"Benedek","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/14728222.2019.1656718","article-title":"Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus","volume":"23","author":"Bilsborrow","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.burns.2016.02.005","article-title":"The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn","volume":"42","author":"Kim","year":"2016","journal-title":"Burns"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3389\/fimmu.2018.01132","article-title":"Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma","volume":"9","author":"Figueiredo","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.1102152","article-title":"Role of Macrophage Migration Inhibitory Factor in the Regulatory T Cell Response of Tumor-Bearing Mice","volume":"189","author":"Choi","year":"2012","journal-title":"J. Immunol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"110977","DOI":"10.1016\/j.celrep.2022.110977","article-title":"Single-cell RNA-seq of a soft-tissue sarcoma model reveals the critical role of tumor-expressed MIF in shaping macrophage heterogeneity","volume":"39","author":"Tessaro","year":"2022","journal-title":"Cell Rep."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ijc.25991","article-title":"Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation","volume":"129","author":"Dumitru","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1089\/scd.2008.0321","article-title":"The epithelial-mesenchymal transition promotes transdifferentiation of subcutaneously implanted hepatic oval cells into mesenchymal tumor tissue","volume":"18","author":"Dong","year":"2009","journal-title":"Stem Cells Dev."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Yamini, B. (2018). NF-kappaB, Mesenchymal Differentiation and Glioblastoma. Cells, 7.","DOI":"10.3390\/cells7090125"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2015.01.010","article-title":"Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1alpha-ZEB1 axis","volume":"359","author":"Joseph","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41232-022-00197-8","article-title":"The roles and mechanisms of senescence-associated secretory phenotype (SASP): Can it be controlled by senolysis?","volume":"42","author":"Ohtani","year":"2022","journal-title":"Inflamm. Regen."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"645593","DOI":"10.3389\/fcell.2021.645593","article-title":"Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype","volume":"9","author":"Kumari","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1038\/s41467-022-32552-1","article-title":"A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues","volume":"13","author":"Saul","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1096\/fj.14-256636","article-title":"Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment","volume":"28","author":"Rajasekaran","year":"2014","journal-title":"Faseb J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/s-0039-1677803","article-title":"Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation","volume":"119","author":"Sinitski","year":"2019","journal-title":"Thromb. Haemost."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc1913","article-title":"Comparing antibody and small-molecule therapies for cancer","volume":"6","author":"Imai","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1038\/s41598-020-63778-y","article-title":"MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo","volume":"10","author":"Cheng","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/MCB.01907-08","article-title":"A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation","volume":"29","author":"Kaleswarapu","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Scheyltjens","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1038\/s41598-019-39427-4","article-title":"Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF)","volume":"9","author":"Ha","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1530\/ERC-15-0299","article-title":"4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas","volume":"22","author":"Varinelli","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1096\/fj.201701189R","article-title":"Novel half-life extended anti-MIF nanobodies protect against endotoxic shock","volume":"32","author":"Sparkes","year":"2018","journal-title":"Faseb J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fonc.2020.01182","article-title":"Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics","volume":"10","author":"Yang","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3389\/fimmu.2017.01746","article-title":"Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers","volume":"8","author":"Arezumand","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.bbagen.2013.04.023","article-title":"Albumin as a versatile platform for drug half-life extension","volume":"1830","author":"Sleep","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3748\/wjg.v18.i18.2253","article-title":"CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer","volume":"18","author":"Zheng","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1111\/bph.15622","article-title":"Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma","volume":"178","author":"Wirtz","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/bjh.12565","article-title":"Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma","volume":"163","author":"Kaufman","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/bjh.14726","article-title":"A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach","volume":"182","author":"Haran","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11011-016-9798-x","article-title":"Predicted structure of MIF\/CD74 and RTL1000\/CD74 complexes","volume":"31","author":"Benedek","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2010.09.013","article-title":"RTL therapy for multiple sclerosis: A Phase I clinical study","volume":"231","author":"Offner","year":"2011","journal-title":"J. Neuroimmunol"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1096\/fj.10-168559","article-title":"MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism","volume":"25","author":"Kraemer","year":"2010","journal-title":"FASEB J."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: Historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/2\/395\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:02:16Z","timestamp":1760119336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/2\/395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":168,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["cancers15020395"],"URL":"https:\/\/doi.org\/10.3390\/cancers15020395","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]}}}